BioLineRx names new board member
This article was originally published in Scrip
Executive Summary
Jerusalem-based biopharmaceutical company BioLineRx, which is focused on in-licensing and developing therapeutic candidates, has named Dr Sandra Panem to its board of directors – effective from 24 February 2014. Dr Panem is currently a managing partner at Cross Atlantic Partners and is on the board of directors for Acorda Therapeutics, GenomeQuest, Labcyte, and MDx Medical.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.